A study of Pliant PLN-74809-PSC-203 (H-48040)
Description
Content
Pliant pln-74809-psc-203: A randomized, double-blind, dose-ranging, placebo-controlled, phase 2a evaluation of the safety, tolerability, and pharmacokinetics of pln-74809 in participants with primary sclerosing cholangitis (psc) and suspected liver fibrosis (integris-psc)
Contact
Phone 1: 713–798–1037
IRB: H-48040
Status:
Active
Created:
